Back to Research Hub
GRAIL Inc.
GRAL
$81.04+0.48 (+0.60%)
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic…
StreetsValue research for GRAIL Inc. (GRAL)
Members get the full report for GRAIL Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.